Challenges and proposals for scaling up COVID-19 testing and diagnosis in Brazil
Cien Saude Colet. 2020 Sep;25(9):3355-3364.
doi: 10.1590/1413-81232020259.17812020.
Epub 2020 Aug 28.
[Article in
English,
Portuguese]
Affiliations
- 1 Departamento de Ciências da Vida, Universidade do Estado da Bahia, Salvador, BA, Brazil, laiomagnoss@gmail.com.
- 2 Departamento de Análises Clínicas e Toxicológicas, Faculdade de Farmácia, Universidade Federal da Bahia, Salvador, BA, Brazil.
- 3 Instituto Multidisciplinar em Saúde, UFBA, Vitória da Conquista, BA, Brazil.
- 4 Instituto de Saúde Coletiva, UFBA, Salvador, BA, Brazil.
Abstract
The Brazilian context of social inequalities and barriers in accessing health services may deteriorate the situation of the COVID-19 pandemic, which already affects all Brazilian federative states, with the growing curve of increasing confirmed cases and deaths. National governments and scientific field agents have been looking for evidence for the best practices of prevention and control of transmission, and care of infection and disease, including diagnosis, treatment, and health care measures. The large-scale testing strategy, aimed at early diagnosis, quarantine of the mild cases identified, as well as those of the contacts, and adequate care of severe cases, has been revised and indicated as one of the efficient pandemic control measures in several countries in the world. This paper aims to discuss the challenges of COVID-19 testing and diagnosis in Brazil.
MeSH terms
-
Brazil
-
COVID-19
-
COVID-19 Testing
-
Clinical Laboratory Techniques*
-
Coronavirus Infections / diagnosis*
-
Coronavirus Infections / epidemiology
-
Health Services Accessibility*
-
Healthcare Disparities
-
Humans
-
Pandemics
-
Pneumonia, Viral / diagnosis*
-
Pneumonia, Viral / epidemiology